about
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX...
Read More
8.22
0.22
(2.75%)
190.3K
XNAS Volume
XNAS 04 Dec, 2025 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bullish
enGene Holdings Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..